ARTICLES BY THIS AUTHOR

• 2/8/2010

  Nilotinib bests imatinib in chronic myeloid leukemia

  Questions about tolerability and cost of treatment need answering before clinical practice should change
• 2/8/2010

  How to tackle no-shows

• 2/8/2010

  Natural products targeting diabetes vary in value

  While products in question seem safe, not all boast effectiveness.
• 2/8/2010

  Vyvanse for ADHD

• 2/8/2010

  Wait times for diagnosis exceed accepted targets

• 2/8/2010

  Negation exemptions needed for focused-practice visits, says OMA head

• 2/8/2010

  Male doctors can be liberated

• 2/8/2010

  Who is Soapy?

  Orange superhero fights germs in Winnipeg
• 2/8/2010

  Can OMA/gov’t meet unattached patients goal?

• 2/8/2010

  Prescription chart toppers

  The top prescription drugs in Canada: a special report prepared by IMS Health